Together these data support the conclusion that JAKinibs inhibit the TNF-induced, IRF1-mediated activation of the JAK-STAT pathway and the subsequent expression of IRGs (Fig. 5d) in RA-FLSs. This evidence concerns the gene TNF and rheumatoid arthritis.